BPC-157
Last reviewed
Also known as: Body Protection Compound-157, PL 14736
BPC-157 is a synthetic peptide derived from a protein found in gastric juice, studied in animal research for accelerating injury recovery and gut tissue repair.
Promotes angiogenesis, collagen deposition, and modulates growth factors for accelerated healing. Acts on multiple repair pathways simultaneously including tendon, ligament, muscle, gut lining, and ne
⚠️ Educational only · Not medical advice · Consult a doctor · Most peptides are research-only / not FDA-approved for human use
§ AI Reference Summary
BPC-157 (also known as Body Protection Compound-157, PL 14736) is a prominently researched experimental compound classified strictly within the Body Protective Compound framework. Operating primarily through advanced pharmacological pathways, its core mechanism of action is as follows: it promotes angiogenesis, collagen deposition, and modulates growth factors for accelerated healing. Acts on multiple repair pathways simultaneously including tendon, ligament, muscle, gut lining, and nerve tissue. with a documented biological half-life of roughly 4 hours, In preclinical investigative trials and independent academic studies, researchers utilizing BPC-157 have documented significant, quantifiable biological outcomes, primarily focusing on injury recovery, gut healing, tissue repair, reduced inflammation. Typical research protocols investigate administering 250 to 500mcg via subq pathways 7x/wk. However, it is critically important to understand that while BPC-157 demonstrates profound physiological potential in highly controlled laboratory settings, it remains classified strictly as a research chemical and has not been approved by the United States Food and Drug Administration (FDA) for human therapeutic, diagnostic, or dietary consumption. Independent chemical analysis via rigorous third-party Certificate of Analysis (COA) testing utilizing High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) remains the industry gold standard for verifying its base elemental stability when reconstituted appropriately in sterile bacteriostatic water.
§ Mechanism of Action
Promotes angiogenesis, collagen deposition, and modulates growth factors for accelerated healing. Acts on multiple repair pathways simultaneously including tendon, ligament, muscle, gut lining, and nerve tissue.
§ Primary Benefits
- 1Injury recovery
- 2gut healing
- 3tissue repair
- 4reduced inflammation
§ Clinical Evidence
BPC-157 tendon, ligament, and gut healing effects
Comprehensive review demonstrating potent tendon, ligament, and gut healing effects across multiple preclinical models.
PreclinicalStable gastric pentadecapeptide BPC 157 gastrointestinal tract healing
Robert et al. demonstrate BPC-157 heals GI ulcers, fistulas, and inflammatory bowel lesions in rats via cytoprotective pathways. Published in Current Pharmaceutical Design.
PreclinicalBPC-157 accelerates Achilles tendon healing in rats
Staresinic et al. show BPC-157 accelerates healing of transected Achilles tendons, enhancing tendon fibroblast outgrowth and survival via FAK-paxillin signaling.
PreclinicalBPC-157 systematic review: musculoskeletal healing (2025)
Systematic review of 35 preclinical and 1 clinical study (1993-2024). BPC-157 promotes angiogenesis, collagen synthesis, and reduces inflammatory cytokines across muscle, tendon, ligament, and bone injury models.
PreclinicalBPC-157 and neuroprotection: stroke and spinal cord models
Preclinical evidence showing BPC-157 counteracts stroke-induced neuronal damage and improves functional recovery after spinal cord compression in rats.
PreclinicalBPC-157 angiogenic and vascular protective effects
Demonstrates BPC-157's strong angiogenic potential via VEGFR2-Akt-eNOS pathway activation, endothelium protection, and reversal of thrombus formation.
PreclinicalTherapeutic peptides in gerontology: mechanisms and applications for healthy aging.
Therapeutic peptides offer mechanistically diverse approaches to targeting fundamental hallmarks of aging, a 2026 review demonstrated. While FDA-approved agents show clinical potential, investigational peptides require rigorous validation through well-designed trials to establish long-term safety and efficacy.
EmergingSafety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance.
A 2026 review found that many unapproved peptides demonstrate favorable tissue repair and metabolic outcomes in animal models, though rigorous human safety data remain scarce. The study investigated the pharmacological mechanisms and regulatory status of various sports medicine peptides.
EmergingCytoprotection as a Unifying Strategy for Hemorrhage and Thrombosis: The Role of BPC 157 and Related Therapeutics.
A 2026 review found that the peptide BPC 157 simultaneously counteracted both hemorrhage and thrombosis in rodent models without directly affecting the coagulation cascade. The study demonstrated that BPC 157 acts as a cytoprotective mediator by preserving endothelial integrity and normalizing microcirculation.
PreclinicalFrom Regeneration to Analgesia: The Role of BPC-157 in Tissue Repair and Pain Management.
A 2026 review found that BPC-157 supports angiogenesis, collagen synthesis, and tissue repair across diverse preclinical models. While animal data demonstrated enhanced healing and pain modulation, human research remains limited to small pilot studies requiring further clinical validation.
Emerging§ Safety Profile
Excellent research safety profile; commonly used for recovery. Not FDA-approved. Most evidence from animal models. FDA restricted use in compounded medications in Sept 2023.
See our evidence grading methodology for how we evaluate and grade peptide safety data.
§ Dosing Protocol
⚠️ For educational purposes only. Not medical advice. Consult a healthcare professional before using any peptide.
RouteSubQ
Dose Range250–500 mcg
Frequency7x/wk
TimingMorning or split AM/PM
Cycle Length4–8 weeks
BAC Water2.5 ml / 5mg vial
Often run 250mcg 2x/day for injuries. Can be injected near injury site.
§ Pharmacokinetics
⏱️ Half-Life: 4h
Plasma concentration over time§ Regulatory
🇺🇸USA
Research Only🇨🇦Canada
Research Only🇬🇧UK
Unregulated🇪🇺EU
Unregulated🇦🇺Australia
Prescription OnlyLast updated: 2026-01 · Laws change frequently. Verify current status in your jurisdiction.
§ Expected Outcomes
Week 1
Reduced pain/inflammation at injury site; improved GI comfort if used for gut healing
Weeks 2–4
Noticeable mobility improvement; significant reduction in injury-site swelling
Month 2–3
Substantial tissue remodeling; most acute injuries showing measurable repair
Long-term
Full tendon/ligament functional recovery in most preclinical models; sustained GI remission
§ Adverse Effects
| Side Effect | Incidence | Severity |
|---|---|---|
Lightheadedness | ~5% of users | mild |
Nausea (especially oral route) | ~3-5% of users | mild |
Vivid dreams | ~5% of users | mild |
Euphoria / mood lift Often not considered adverse; may reflect CNS activity | ~8% of users | mild |
Verified Source
Sourcing BPC-157 from Amino Club
We've independently verified Amino Club's third-party testing standards and pricing for BPC-157. Read our full analysis and get 20% off your order.
Where to Source BPC-157 for Research
Finding verified, high-purity BPC-157 requires rigorous COA verification. We independently evaluate vendors based on third-party HPLC testing, purity thresholds (≥98%), and batch-specific documentation.
View COA-Verified BPC-157✓ Third-party tested·✓ US shipping·✓ COA on every batch
Disclosure: PeptiDex may earn a commission from purchases made through affiliate links. This does not affect our editorial independence or recommendations. We exclusively feature vendors that pass our strict quality verification protocols.
Reconstitution CalculatorCalculate reconstitution for BPC-157 →
Compare ToolCompare BPC-157 to similar peptides →
Frequently Asked Questions
Related Articles
BPC-157 Dosage Guide: Complete Research Protocols for 2026
A comprehensive, evidence-based research guide to BPC-157 dosage protocols. We cover systemic vs local administration, reconstitution math, cycle lengths, and stacking.
Science Explainers2026-04-30
Peptide Cycle Length: A Complete Research Guide for 2026
A comprehensive scientific guide to peptide cycle lengths. We explain receptor downregulation, angiogenic risks, and how to safely cycle BPC-157, TB-500, and secretagogues.
Science Explainers2026-04-30
Best Peptide Stack for Injury Recovery in 2026: A Research Guide
A deep dive into the best peptide stacks for injury recovery. We analyze the synergistic effects of BPC-157, TB-500, and growth hormone secretagogues for tissue repair.
Research News2026-04-30
Peptide Stacking in 2026: Why Combination Protocols Are Redefining Results
A deep dive into peptide stacking protocols — the Wolverine stack (BPC-157 & TB-500), growth hormone synergy (CJC-1295 & Ipamorelin), longevity and cognitive stacks, and how to combine compounds effectively.
Science Explainers2026-04-13
§ Comparisons
§ Community Stacks
Cite This Page
Free Download
2026 Peptide Stack Cheat Sheet
12 stacks • exact dosages • cycle lengths • printable reference
No spam. Unsubscribe anytime.
§ About the Author
Dr. E. Vance
Editorial Director, PeptiDex
Dr. E. Vance is the Editorial Director at PeptiDex and leads the platform's editorial division, ensuring that every published research summary meets rigorous preclinical citation standards. With a Ph.D. in Molecular Pharmacology from Columbia Univers...
View Full ProfileLast fact-checked: · PeptiDex Editorial Team
⚠ Educational only · Not medical advice · Most peptides are research-only / not FDA-approved